Target intelligence / Profile preview

Cardiomyocyte membrane potential

Molecular classification
Other (physiological property, not a molecule)
01

Overview

The **cardiomyocyte membrane potential** is the voltage difference between the inside and outside of a cardiac muscle cell, maintained primarily by ionic concentration gradients (especially potassium, sodium, and calcium) across the plasma membrane and the selective permeability of various ion channels[7][8][3]. In resting (non-pacemaker) cardiomyocytes, this potential is approximately −90 mV[7]. Depolarization and repolarization events, which underpin the cardiac action potential, are orchestrated by the coordinated opening and closing of voltage-gated sodium, potassium, and calcium channels, as well as the action of ion pumps such as the Na+/K+ ATPase[2][4][8]. The membrane potential is central to proper heart function: disruption can lead to conduction disorders, arrhythmias, or cardiomyopathy[6][7][5]. "Cardiomyocyte membrane potential" refers to a crucial physical property of heart muscle cells rather than a molecular therapeutic target. Drugs influence this property by targeting underlying ion channels responsible for ionic currents[2][6][7].

Other names
Cardiomyocyte resting membrane potentialCardiac myocyte membrane potentialCardiac action potential (partially overlapping concept)
02

Mechanism of action

Modulation of ion channel activity (e.g., sodium, potassium, calcium channel blockers, openers)

03

Biological functions

Electrical excitabilityExcitation–contraction couplingCardiac electrical signal conductionRegulation of heart rhythm
04

Disease associations

Cardiovascular disease (arrhythmias, heart failure)Sudden cardiac death
05

Safety considerations

Risk of drug-induced arrhythmias (e.g., torsades de pointes from prolonged action potential)Proarrhythmic effects of ion channel modulators
06

Interacting drugs

lidocaine

6 more in the full profile.

07

Biomarkers

Electrophysiological parameters (e.g., QT interval on ECG, action potential duration)

Beyond the preview

Go deeper on Cardiomyocyte membrane potential.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiomyocyte membrane potential.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call